Fundación Cardiovascular de Colombia - Instituto Cardiovascular - Bucaramanga
Fundación Cardiovascular de Colombia - Instituto Cardiovascular - Bucaramanga
Carrera 49C # 82 - 85, Barranquilla, Atlántico
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Jaime Orlando Ibarra Gómez
Heidy Luz Serrano Montenegro
Open studies
Esophageal cancer
Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. - FORTITUDE-102 - Amgen
Gastric cancer
Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. - FORTITUDE-102 - Amgen
Gastroesophageal cancer
Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. - FORTITUDE-102 - Amgen
